Based on the typical UK regulatory pathway, the most realistic timeline is: Late 2026 / early 2027: Eli Lilly expected to submit regulatory filings to the FDA and MHRA following completion of the remaining TRIUMPH Phase 3 readouts Late 2027 to mid-2028: Possible MHRA marketing authorisation, allowing private UK prescribing 2028 to 2029 onwards: Possible NHS availability following a NICE technology appraisal and NHS commissioning decisions Timelines may differ across the four UK nations, as Scotland, Wales, and Northern Ireland assess medicines separately through the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), and the Department of Health Northern Ireland respectively
In Mondays ruling, the judge did grant Mochi Healths request to dismiss Lillys civil conspiracy claim because, she said, the amended complaint does not include allegations supporting a plausible inference of an agreement to a common plan among Mochi Health, the Mochi Medical defendants, and Aequita Pharmacy
Banza chickpea pasta has nearly double the protein of regular pasta (13g vs 7g per serving) and more than double the fiber
Image Credit: thesomegirl.2
This user has lost 77 pounds (34.9 kg) since starting Wegovy, going from 264 lbs (119.7 kg) to 187 lbs (84.8 kg)
By improving these biochemical processes, B-Complex Injections support sustained physical and cognitive performance
